Successful treatment with a short course of remdesivir in a case of prolonged COVID-19 in a lymphoma patient

Mikael Kajovaa Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, FinlandCorrespondence[email protected]

Eliisa Kekäläinenb HUS Diagnostic Center, HUSLAB, Clinical Microbiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland;c Translational Immunology Research Program and Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland

Veli-Jukka Anttilaa Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Juuso Paajanend Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

Successful treatment with a short course of remdesivir in a case of prolonged COVID-19 in a lymphoma patient

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Successful treatment with a short course of remdesivir in a case of prolonged COVID-19 in a lymphoma patient

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date